The iconic rise of Viagra has firmly established as a example of pharmaceutical success, yet its future within the broader market now raises questions about long-term gains. Generic versions are diminishing patent protection , prompting worries that supporting companies heavily reliant to Viagra's former position could be a speculative decision , e